19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine
C22H43N3 — CID 57169148
Data last refreshed: (MolForge compound catalog, from PubChem)
About 19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine
19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine (PubChem CID 57169148) has the molecular formula C22H43N3 and a molecular weight of 349.61 g/mol. Its IUPAC name is 19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine.
Molecular Properties
| Compound Name | 19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine |
|---|---|
| PubChem CID | 57169148 |
| Molecular Formula | C22H43N3 |
| Molecular Weight | 349.61 g/mol |
| Exact Mass | 349.35 |
| IUPAC Name | 19-(4,5-dihydro-1H-imidazol-2-yl)nonadec-17-en-2-amine |
| SMILES | CC(N)CCCCCCCCCCCCCCC=CCC1=NCCN1 |
| InChI | InChI=1S/C22H43N3/c1-21(23)17-15-13-11-9-7-5-3-2-4-6-8-10-12-14-16-18-22-24-19-20-25-22/h14,16,21H,2-13,15,17-20,23H2,1H3,(H,24,25) |
| InChIKey | UTHRMZTZOTUDMH-UHFFFAOYSA-N |
| XLogP | 5.74 |
| TPSA | 50.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 17 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 349.61 |
| LogP ≤ 5 | 5.74 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 57169148 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.